—Mkt Cap: —P/E: —
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vap…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap—
Enterprise Value242.52M $
Revenue (TTM)309.18M $
Gross Profit90.22M $
Net Income (TTM)-24.76M $
Revenue/Share2.273 USD
Last Price—
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees1.1K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCA68620P1018
Valuation
P/E (Trailing)—
P/E (Forward)50.00
PEG—
EV/EBITDA14.71
EV/Revenue0.78
P/S0.55
P/B0.46
EPS (TTM)0.42
EPS (Forward)0.02
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin34.81%
Oper. Margin5.04%
EBITDA Margin5.33%
Profit Margin-9.55%
ROE-7.09%
ROA-4.40%
Growth
Revenue Growth49.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.59M $
CapEx (TTM)17.05M $
FCF Margin0.14%
FCF Yield—
Net Debt9.31M $
Net Debt/EBITDA0.56
Balance Sheet
Debt/Equity0.03
Current Ratio2.61
Quick Ratio0.94
Book Value/Sh2.590 USD
Cash/Share0.0860 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJul 7, 2023
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.141.01M
Float94.22M
Insiders30.21%
Institutions6.47%
Short Interest
Short Ratio15.1d
Short % Out.3.73%
Shares Short5.27M
Short (prev mo.)4.71M
Technical
SMA 501.011 USD
SMA 2001.358 USD
Beta—
S&P 52W Chg21.00%
Avg Vol (30d)—
Avg Vol (10d)3.15M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—